Search results
IMS Health was best known for its collection of healthcare information spanning sales, de-identified prescription data, medical claims, electronic medical records and social media.
Each IMS ® World Review Executive report provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analyses for different five-year periods, including the breakdown of sales by regions, countries, therapeutic areas, products and companies.
Nov 5, 2009 · Health care data company IMS Health Inc. said Thursday it is being bought by investment funds TPG Capital and CPP Investment Board for $4 billion, in a move to help the company restructure its...
May 3, 2016 · IMS Health Holdings, Inc. (NYSE: IMS) and Quintiles Transnational Holdings Inc. (NYSE: Q) revealed that their respective boards approved a definitive merger deal involving an all-stock merger...
May 3, 2016 · IMS Health and Quintiles agreed to merge in a deal valued at about $9 billion in a move that will create an information technology and data powerhouse in the life sciences industry.
May 3, 2016 · (Reuters) - Contract medical research provider Transnational Holdings Inc will merge with healthcare information company IMS Health Holdings Inc in a deal worth about $9 billion.
IQVIA, formerly Quintiles and IMS Health, Inc., is an American Fortune 500 and S&P 500 multinational company serving the combined industries of health information technology and clinical research.
